Akebia Therapeutics (AKBA) Net Equity Issued and Repurchased (2013 - 2026)
Akebia Therapeutics' Net Equity Issued and Repurchased came in at $131,000 for Q1 2026, down 72.8% from $482,000 a year earlier but up 107.9% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
For FY2025, Akebia Therapeutics' Net Equity Issued and Repurchased was $1.68 million, up 337.4% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 6.6% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $385,000 in FY2024 (+352.9%), $85,000 in FY2023 (-79.3%), $410,000 in FY2022 (-45.0%) and $746,000 in FY2021 (-39.2%).
- The five-year range for quarterly Net Equity Issued and Repurchased is $1,000 (Q4 2023) to $961,000 (Q3 2025).
- The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2024 (growth of 314.7%), and the weakest in Q1 2023 (a decline of 90.7%).
- Business Quant data shows AKBA's Net Equity Issued and Repurchased at $63,000 (Q4 2025), $961,000 (Q3 2025) and $178,000 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Akebia Therapeutics | 250.00 Mn | -419.48 Mn | 38.70 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 131,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 961,000.00 |
| Jun 30, 2025 | 178,000.00 |
| Mar 31, 2025 | 482,000.00 |
| Dec 31, 2024 | 230,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Sep 30, 2022 | 43,000.00 |
| Mar 31, 2022 | 367,000.00 |
| Sep 30, 2021 | 379,000.00 |
| Mar 31, 2021 | 367,000.00 |
| Sep 30, 2020 | 405,000.00 |
| Jun 30, 2020 | 370,000.00 |
| Mar 31, 2020 | 451,000.00 |
| Jun 30, 2019 | 195,000.00 |
| Mar 31, 2019 | 365,000.00 |
API Access
Akebia Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();